Pennsylvania 2025-2026 Regular Session

Pennsylvania House Bill HR174 Latest Draft

Bill / Introduced Version

                             
PRINTER'S NO. 1246 
THE GENERAL ASSEMBLY OF PENNSYLVANIA
HOUSE RESOLUTION 
No.174 
Session of 
2025 
INTRODUCED BY STRUZZI, CONKLIN, FREEMAN, HOHENSTEIN, KHAN, 
McNEILL, NEILSON, REICHARD, VENKAT AND ZIMMERMAN, 
APRIL 3, 2025 
REFERRED TO COMMITTEE ON HEALTH, APRIL 3, 2025 
A RESOLUTION
Recognizing the month of July 2025 as "Juvenile Arthritis 
Awareness Month" in Pennsylvania.
WHEREAS, Juvenile arthritis is an umbrella term that refers 
to pediatric rheumatic diseases that can develop in children 16 
years of age or younger; and
WHEREAS, Juvenile idiopathic arthritis (JIA) is an 
autoinflammatory disease of an unknown origin and the most 
common type of arthritis in children; and
WHEREAS, An autoinflammatory disease causes the immune system 
to become overactive even when there is no infection or illness 
to fight or mistakenly attack healthy cells and tissues; and
WHEREAS, There is no evidence as to what causes JIA and no 
evidence has been found that foods, toxins, allergies or lack of 
vitamins play a role in developing the disease; and
WHEREAS, Current research indicates that there is a genetic 
predisposition to JIA; and
WHEREAS, Researchers believe that a trigger, such as a virus, 
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17 can initiate JIA in a child who has the genetic tendency; and
WHEREAS, Systemic JIA, oligoarticular JIA, polyarticular JIA, 
juvenile psoriatic arthritis, enthesitis-related JIA and 
undifferentiated arthritis are the six subtypes of JIA; and
WHEREAS, Nearly 300,000 children in the United States have 
some form of arthritis; and
WHEREAS, Typical symptoms of arthritis include limping, 
stiffness when awakening, reluctance to use an arm or leg, 
reduced activity level, persistent fever, joint swelling and 
difficulty with fine motor skills; and
WHEREAS, Most children with arthritis can expect to live 
normal lives and some even have their arthritis go into 
remission; and
WHEREAS, There is a small number of specialists who treat 
JIA, and the Children's Hospital of Philadelphia is a leader in 
the field; and
WHEREAS, According to the American College of Rheumatology, 
the best care for a child who has JIA is provided by a pediatric 
rheumatology team that has extensive experience and can diagnose 
and manage their complex needs; and
WHEREAS, A pediatric rheumatology team may consist of a 
pediatric rheumatologist, a physical therapist, an occupational 
therapist, a social worker and a nurse specialist who coordinate 
care with other health professionals and school and community 
officials; and
WHEREAS, The overall treatment goal for a child who has JIA 
is to control the symptoms, prevent joint damage and maintain 
function; and
WHEREAS, Medications, including steroids, disease-modifying 
drugs and biologics, along with physical and occupational 
20250HR0174PN1246 	- 2 - 
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30 therapy, are used to treat JIA; and
WHEREAS, Parents and caregivers of children who have JIA 
should be familiar with 29 U.S.C. Ch. 16, which may provide for 
special accommodations at school; and
WHEREAS, Children who have JIA may be eligible for assistance 
through services provided by State agencies; therefore be it
RESOLVED, That the House of Representatives recognize the 
month of July 2025 as "Juvenile Arthritis Awareness Month" in 
Pennsylvania.
20250HR0174PN1246 	- 3 - 
1
2
3
4
5
6
7
8
9